The MDC spinout raised a series B round which will be used to boost its manufacturing capacity and advance its pipeline of candidates.

University of Toronto-linked Deep Genomics has picked up $180m in its series C round led by SoftBank Vision Fund 2.

UPMC Enterprises has contributed to a $117m series B round for gene therapy developer Ring Therapeutics.

PsiQuantum has become the first unicorn in Imec.xpand’s portfolio as it fetched a valuation of more than $3bn.

IP Group is among the investors backing the DDR cancer therapeutics developer’s latest round, which took its total funding to $320m.

SoftBank’s Vision Fund 2 has invested at a $2.7bn valuation, taking the Stanford-backed life insurance platform developer’s overall funding to over $400m.

ArcelorMittal led a series D round for the rechargeable battery developer spun out of MIT.

The NFT marketplace, which counts Stanford-StartX Fund as an investor, has raised series B funding led by Andreessen Horowitz.

The Oxford-backed corporate education resource provider’s overall funding now stands at more than $280m.

Several corporates helped the Montana State University-backed microbial protein developer take its total funding above $500m.